ThinkGenetic CEO “Disruptor” to Discuss the Patient Perspective of Advancing Clinical Trials

ThinkGenetic CEO, Dave Jacob, is honored to be an invited speaker during the “Ask the Patient” discussions taking place during meals and breaks at the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference September 7-8, 2017 in Boston, MA.

This is the first time ThinkGenetic has attended the pioneering “TED-style” event. It gathers stakeholders to explore radically different approaches to the way clinical trials are performed, featuring novel models and collaborations to help patients access therapeutics faster. Dave’s perspective as a rare genetic disease patient will help ensure a meaningful and productive conversation.

To learn more about the event and events taking place, please scroll below

7th annual DPharm: Disruptive Innovations to Advance Clinical Trials Conference

The Conference Forum is delighted to present the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference. The Conference Forum is dedicated to presenting the annual event that the life science industry can rely on for the latest thinking in clinical trials for 21st century drug development.

• • When: September 7-8, 2017
  • Location: Boston, MA
  • Venue: Marriott Copley Place
  • Register: http://theconferenceforum.org/conferences/disruptive-innovations-us/overview/